Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: European comments to the guidelines of the American Thyroid Association

Thyroid Research

Volumn 6, Issue SUPPL.1, 2013, Pages

  Elisei, Rossella ^a   Romei, Cristina ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875285140     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-6-S1-S2     Document Type: Review

References (35)

1. Medullary thyroid cancer: management guidelines of the American Thyroid Association. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr, Thyroid 2009 19 6 565 612 10.1089/thy.2008.0403 19469690
2. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Tyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, Thyroid 2009 19 11 1167 214 10.1089/thy.2009.0110 19860577
3. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, European Thyroid Cancer Taskforce, Eur J Endocrinol 2006 154 6 787 803 10.1530/eje.1.02158 16728537 (Pubitemid 43997716)
4. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P, AACE/AME/ETA Task Force on Thyroid Nodules, J Endocrinol Invest 2010 33 5 Suppl 51 6 20543551
5. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A, J Clin Endocrinol Metab 1994 78 4 826 9 10.1210/jc.78.4.826 8157706 (Pubitemid 24118072)
6. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP, Clin Endocrinol (Oxf) 1995 42 5 453 60 10.1111/j.1365-2265.1995. tb02662.x 7621562
7. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B, J Clin Endocrinol Metab 1997 82 2 338 41 10.1210/jc.82.2.338 9024213 (Pubitemid 27068587)
8. Routine measurement of plasma calcitonin in nodular thyroid diseases. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B, J Clin Endocrinol Metab 1997 82 5 1589 93 10.1210/jc.82.5.1589 9141554 (Pubitemid 27200439)
9. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B, Am J Surg Pathol 1998 22 6 722 8 10.1097/00000478-199806000-00009 9630179 (Pubitemid 28280274)
10. Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tüzün M, Yetkin E, Tunçyürek M, Kabalak T, Thyroid 1999 9 6 579 82 10.1089/thy.1999.9.579 10411120 (Pubitemid 29296120)
11. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH, Thyroid 2001 11 1 73 80 10.1089/10507250150500694 11272100 (Pubitemid 32140448)
12. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Bieglmayer C, Scheuba C, Niederle B, Flores J, Vierhapper H, Wien Klin Wochenschr 2002 114 7 267 73 12089862 (Pubitemid 34450419)
13. False serum calcitonin high levels using a non-competitive two-site IRMA. Tommasi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M, J Endocrinol Invest 2001 24 5 356 60 11407656 (Pubitemid 32492373)
14. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules. Giovanella L, Suriano S, Head Neck 2011 33 1 95 7 10.1002/hed.21405 20848426
15. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE, Clinics (Sao Paulo) 2009 64 7 699 706 19606248
16. Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. Doyle P, Düren C, Nerlich K, Verburg FA, Grelle I, Jahn H, Fassnacht M, Mäder U, Reiners C, Luster M, J Clin Endocrinol Metab 2009 94 8 2970 4 10.1210/jc.2008-2403 19491231
17. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC, J Clin Endocrinol Metab 1994 78 1 114 20 10.1210/jc.78.1.114 7904611 (Pubitemid 24026758)
18. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma. Samaan NA, Castillo S, Schultz PN, Khalil KG, Johnston DA, J Clin Endocrinol Metab 1980 51 2 237 41 10.1210/jcem-51-2-237 6249833 (Pubitemid 10007625)
19. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L, J Clin Endocrinol Metab 2012 97 3 905 13 10.1210/jc.2011-2033 22170709
20. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S, J Clin Endocrinol Metab 2007 92 2 450 5 17119000
21. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A, Clin Endocrinol (Oxf) 2010 73 1 85 8 20039894
22. Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Verga U, Ferrero S, Vicentini L, Brambilla T, Cirello V, Muzza M, Beck-Peccoz P, Fugazzola L, Endocr Relat Cancer 2007 14 2 393 403 10.1677/ERC-06-0053 17639053 (Pubitemid 47242638)
23. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Elisei R, Best Pract Res Clin Endocrinol Metab 2008 22 6 941 53 10.1016/j.beem.2008.09.008 19041824
24. The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. Elisei R, Romei C, Renzini G, Bottici V, Cosci B, Molinaro E, Agate L, Cappagli V, Miccoli P, Berti P, Faviana P, Ugolini C, Basolo F, Vitti P, Pinchera A, J Clin Endocrinol Metab 2012 97 2 426 35 10.1210/jc.2011-2046 22162466
25. The calcitonin conundrum - is it time for routine measurement of serum calcitonin in patients with thyroid nodules? Hodak SP, Burman KD, J Clin Endocrinol Metab 2004 89 2 511 4 10.1210/jc.2003-031983 14764754 (Pubitemid 38269850)
26. Should serum calcitonin be routinely measured in patients with thyroid nodules - will the law answer before endocrinologists do? Deftos LJ, J Clin Endocrinol Metab 2004 89 9 4768 9 author reply 4769-70 15356093
27. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F, J Clin Endocrinol Metab 2004 89 1 163 8 10.1210/jc.2003-030550 14715844 (Pubitemid 38183876)
28. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S, Thyroid 2005 15 11 1267 72 10.1089/thy.2005.15.1267 16356091 (Pubitemid 41821761)
29. The prevalence of occult medullary thyroid carcinoma at autopsy. Valle LA, Kloos RT, J Clin Endocrinol Metab 2011 96 1 109 13 10.1210/jc.2010-0959 20943788
30. Screening of thyroid nodules by serum calcitonin measurements: why not? Pacini F, Thyroid 2012 22 1 103 10.1089/thy.2011.0394 22136185
31. Micromedullary thyroid cancer: how micro is truly micro? Pillarisetty VG, Katz SC, Ghossein RA, Tuttle RM, Shaha AR, Ann Surg Oncol 2009 16 10 2875 81 10.1245/s10434-009-0595-1 19568813
32. Increasing incidence of thyroid cancer in the United States, 1973-2002. Davies L, Welch HG, JAMA 2006 295 18 2164 7 10.1001/jama.295.18.2164 16684987
33. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. Ahmed SR, Ball DW, J Clin Endocrinol Metab 2011 96 5 1237 45 10.1210/jc.2010-2359 21346073
34. Incidentally found medullary thyroid cancer: treatment rationale for small tumors. Raffel A, Cupisti K, Krausch M, Wolf A, Schulte KM, Röher HD, World J Surg 2004 28 4 397 401 10.1007/s00268-003-7121-6 14994142 (Pubitemid 38525875)
35. Calcitonin Measurement in the Evaluation of Thyroid Nodules in the United States: A Cost-effectiveness and Decision Analysis. Cheung K, Roman SA, Wang TS, Walker HD, Sosa JA, J Clin Endocrinol Metab 2008 93 6 2173 80 10.1210/jc.2007-2496 18364376 (Pubitemid 351831532)